SCF ENCYCLOPEDIA ENTRY
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHIES (HSAN)
SCF PERIPHERAL NEUROSENSORY FAILURE & AUTONOMIC INTELLIGENCE SYNCHRONIZATION COLLAPSE DOSSIER
I. OFFICIAL DISEASE CLASSIFICATION
Category | Classification |
Disease Name | Hereditary Sensory and Autonomic Neuropathies |
Alternative Names | HSAN Disorders, Hereditary Sensory Neuropathies |
Disease Family | Inherited Peripheral Neuropathies |
SCF Classification | Peripheral Sensory Signaling & Autonomic Synchronization Failure Disorders |
Primary Clinical Domain | Neurology, Medical Genetics, Pain Biology, Autonomic Medicine & Neurodevelopment |
Core Pathology | Genetic degeneration or dysfunction of sensory and autonomic neurons leading to impaired pain perception, temperature sensation abnormalities, autonomic dysfunction, tissue injury, and progressive neurologic complications |
Principal Failure Axis | Sensory neuron degeneration + autonomic dysfunction + protective signaling loss + tissue injury + systemic dysregulation |
SCF Fault Tier | Tier IV–V Neurocommunication Failure Syndromes |
HSAN disorders belong to SCF Clinical Domains C7 (Neurology), C1 (Genomic Medicine), C13 (Neurobiology), C11 (Vascular Biology), and C2 (Cellular Signaling).
II. CLINICAL DEFINITION
Hereditary Sensory and Autonomic Neuropathies comprise a group of inherited disorders characterized by:
- Impaired pain perception
- Loss of temperature sensation
- Peripheral neuropathy
- Autonomic dysfunction
- Recurrent injuries
- Progressive neurodegeneration
Primary affected systems:
- Peripheral sensory neurons
- Dorsal root ganglia
- Small-fiber nerve networks
- Sympathetic nervous system
- Parasympathetic nervous system
- Peripheral autonomic ganglia
Associated conditions:
- Peripheral neuropathy
- Autonomic dysfunction
III. MAJOR CLASSIFICATIONS
A. HSAN Type I
Feature | Description |
Onset | Adolescence or adulthood |
Inheritance | Usually autosomal dominant |
Hallmark | Progressive distal sensory loss |
Associated condition:
- Hereditary sensory neuropathy type I
B. HSAN Type II
Feature | Description |
Onset | Infancy |
Hallmark | Severe sensory loss |
Inheritance | Autosomal recessive |
C. HSAN Type III
Feature | Description |
Name | Familial Dysautonomia |
Gene | ELP1 (IKBKAP) |
Hallmark | Severe autonomic dysfunction |
Associated condition:
- Familial dysautonomia
D. HSAN Type IV
Feature | Description |
Gene | NTRK1 |
Hallmark | Congenital insensitivity to pain with anhidrosis |
Severity | Severe |
Associated condition:
- Congenital insensitivity to pain with anhidrosis
E. HSAN Type V
Feature | Description |
Gene | NGF |
Hallmark | Reduced pain perception with milder autonomic involvement |
IV. CORE SCF ETIOPATHOGENIC THESIS
Within the Synergistic Compatibility Framework (SCF), HSAN disorders represent a systems-level collapse of:
- Sensory surveillance harmonics
- Protective pain-signaling systems
- Autonomic regulation fidelity
- Environmental-response intelligence
- Peripheral neural synchronization networks
SCF interprets HSAN disorders as decentralized biological intelligence failures in which the body’s danger-detection and homeostatic-regulation systems lose the ability to communicate threats and maintain physiologic equilibrium.
V. SENSORY–AUTONOMIC FOUNDATION
Physiologic Roles of Sensory & Autonomic Systems
These systems coordinate:
- Pain detection
- Temperature sensing
- Tissue protection
- Cardiovascular regulation
- Sweating
- Gastrointestinal control
- Homeostasis maintenance
Core Pathophysiologic Mechanisms
Mechanism | Consequence |
Sensory neuron degeneration | Loss of pain sensation |
Small-fiber neuropathy | Temperature perception deficits |
Autonomic ganglion dysfunction | Dysautonomia |
Protective signaling failure | Recurrent injury |
Impaired sweating | Thermoregulation abnormalities |
Chronic tissue damage | Progressive disability |
VI. MAJOR GENETIC CAUSES
Principal Genes
Gene | Associated Disorder |
SPTLC1 | HSAN Type I |
SPTLC2 | HSAN Type I |
ATL1 | Sensory neuropathy variants |
ELP1 | Familial dysautonomia |
NTRK1 | HSAN Type IV |
NGF | HSAN Type V |
DNMT1 | Sensory-autonomic neuropathy syndromes |
WNK1 | HSAN Type II variants |
Genetic Characteristics
Feature | Description |
Inheritance | Autosomal dominant or recessive |
Onset | Infancy to adulthood |
Progression | Variable |
Penetrance | Variable |
VII. SCF FAULT ARCHITECTURE
SCF Fault Node | Biological Consequence |
Sensory neuron loss | Pain signaling failure |
Small-fiber degeneration | Thermal sensing impairment |
Autonomic dysfunction | Homeostatic instability |
Injury detection failure | Tissue destruction |
Vascular dysregulation | Circulatory abnormalities |
Sweat-gland dysfunction | Heat intolerance |
Neuroimmune dysregulation | Secondary inflammation |
Peripheral communication collapse | Environmental-response failure |
Sensory-autonomic synchronization failure | Progressive systemic dysfunction |
VIII. MULTI-OMICS PATHOGENESIS
A. Genomics
Affected pathways:
- Neurotrophin signaling
- Sensory neuron development
- Axonal maintenance
- Autonomic regulation
B. Transcriptomics
Dysregulated pathways:
- Neurodevelopment
- Axonal repair
- Synaptic signaling
- Stress adaptation
C. Proteomics
Observed abnormalities:
- Neurotrophic factors
- Axonal proteins
- Synaptic regulators
- Autonomic signaling proteins
D. Metabolomics
Key dysfunction:
- Neuronal energy stress
- Oxidative injury
- Neurotransmitter imbalance
- Peripheral tissue degeneration
E. Neuroinformaticomics (SCF)
Observed abnormalities:
- Threat-detection failure
- Sensory communication collapse
- Homeostatic signaling instability
- Environmental-response impairment
IX. SCF PATHOGENESIS FLOW
Stage 1 — Genetic Mutation
Sensory or autonomic neuronal development becomes impaired.
Stage 2 — Neural Dysfunction
Peripheral signaling efficiency declines.
Stage 3 — Sensory Loss
Pain and temperature perception diminish.
Stage 4 — Autonomic Dysregulation
Sweating, cardiovascular, and gastrointestinal abnormalities emerge.
Stage 5 — Recurrent Injury
Protective responses fail.
Stage 6 — Progressive Disability
Chronic tissue damage and neurologic decline develop.
X. SYSTEMIC CONSEQUENCES
Consequence | Mechanism |
Pain insensitivity | Sensory neuron dysfunction |
Self-injury | Loss of protective feedback |
Chronic ulcers | Repeated unnoticed trauma |
Osteomyelitis | Secondary infections |
Dysautonomia | Autonomic failure |
Thermoregulatory dysfunction | Sweat-gland impairment |
Associated conditions:
- Osteomyelitis
- Dysautonomia
- Neuropathic ulcer
XI. RHENOVA INTERPRETATION
Project RHENOVA interprets HSAN disorders as biologic threat-detection destabilization syndromes.
RHENOVA Dynamics
- Danger-signal loss loops
- Autonomic instability cascades
- Tissue injury amplification
- Environmental-response failure
- Neural synchronization collapse
RHENOVA Biomarkers
Biomarker | Significance |
Nerve conduction studies | Peripheral nerve assessment |
Quantitative sensory testing | Sensory function evaluation |
Skin biopsy | Small-fiber nerve density |
Autonomic testing | Dysautonomia assessment |
Genetic testing | Molecular diagnosis |
XII. DBI INTERPRETATION
The SCF Decentralized Biological Intelligence framework interprets sensory and autonomic networks as biological surveillance and control systems coordinating:
- Threat detection
- Environmental monitoring
- Tissue protection
- Internal regulation
- Adaptive responses
DBI Failure Features
- Threat-blindness
- Environmental-response disruption
- Homeostatic instability
- Communication fragmentation
This transforms adaptive biologic intelligence into progressive self-injury and physiologic dysregulation.
XIII. CLINICAL MANIFESTATIONS
Sensory Manifestations
- Pain insensitivity
- Reduced temperature perception
- Numbness
- Distal sensory loss
Associated condition:
- Hypoesthesia
Autonomic Manifestations
- Anhidrosis
- Orthostatic hypotension
- Gastrointestinal dysmotility
- Abnormal tear production
Associated conditions:
- Anhidrosis
- Orthostatic hypotension
Musculoskeletal Manifestations
- Charcot joints
- Fractures
- Deformities
- Osteomyelitis
Associated condition:
- Neuropathic arthropathy
Pediatric Manifestations
- Self-mutilation
- Tongue biting
- Recurrent injuries
- Delayed diagnosis of trauma
XIV. DIAGNOSTICS
Modality | Utility |
Genetic testing | Definitive diagnosis |
Nerve conduction studies | Neuropathy assessment |
Quantitative sensory testing | Sensory evaluation |
Skin biopsy | Small-fiber neuropathy confirmation |
Autonomic reflex testing | Dysautonomia assessment |
Diagnostic Hallmarks
Neural principle:
Sensory\ Neuron\ Dysfunction \Rightarrow Pain\ Signal\ Failure
Autonomic relationship:
Autonomic\ Network\ Failure \Rightarrow Homeostatic\ Dysregulation
Clinical consequence:
Protective\ Signal\ Loss \Rightarrow Injury\ +\ Tissue\ Destruction
XV. SCF SYSTEMIC AXIS INVOLVEMENT
Axis | Dysfunction |
Sensory Axis | Pain perception failure |
Autonomic Axis | Homeostatic instability |
Vascular Axis | Circulatory dysregulation |
Thermoregulatory Axis | Sweating abnormalities |
Neuroimmune Axis | Secondary inflammatory injury |
Protective Intelligence Axis | Threat-detection failure |
XVI. STANDARD OF CARE
Current Management
No universal curative therapy currently exists.
Management focuses on:
- Injury prevention
- Wound care
- Orthopedic management
- Autonomic symptom control
- Physical rehabilitation
Symptomatic Therapies
Examples:
- Midodrine
- Fludrocortisone
Supportive Care
Therapy | Purpose |
Protective footwear | Injury prevention |
Wound surveillance | Ulcer prevention |
Physical therapy | Mobility preservation |
Autonomic monitoring | Dysautonomia management |
XVII. SCF-PCR THERAPEUTIC ARCHITECTURE
A. Preventative (PCR-P)
Goals:
- Prevent tissue injury
- Reduce infection risk
- Preserve function
B. Curative (PCR-C)
Goals:
- Restore sensory neuron function
- Correct genetic defects
- Normalize autonomic signaling
C. Restorative (PCR-R)
Goals:
- Restore neural resilience
- Improve autonomic stability
- Enhance tissue protection
- Rebuild sensory-autonomic synchronization harmonics
XVIII. ETHNOBIOPROSPECTING TARGETS
Note: These represent exploratory neuroregenerative research targets and not established disease-modifying therapies.
Traditional Chinese Medicine
- Astragalus membranaceus
- Gastrodia elata
Ayurveda
- Withania somnifera
- Bacopa monnieri
Vietnamese Thuốc Nam
- Centella asiatica
XIX. SCF API DISCOVERY TARGETS
High-Priority Molecular Targets
- Neurotrophin restoration technologies
- NTRK1 signaling enhancement platforms
- Peripheral nerve regeneration systems
- Small-fiber neuroprotection pathways
- Autonomic stabilization therapeutics
- Axonal repair technologies
- Sensory-autonomic synchronization restoration systems
XX. SCF LAYMAN’S SUMMARY
Hereditary Sensory and Autonomic Neuropathies (HSANs) are rare genetic disorders that damage the nerves responsible for sensing pain, temperature, and regulating automatic body functions such as sweating, blood pressure, and digestion. Because affected individuals may not feel pain normally, they are prone to repeated injuries, infections, fractures, and joint destruction. Some forms also cause severe autonomic dysfunction affecting breathing, circulation, temperature regulation, and gastrointestinal function. SCF interprets HSAN disorders as failures of the body’s biological surveillance and protective-intelligence systems, where threat detection, injury signaling, and autonomic regulation become progressively disconnected.
XXI. STRATEGIC RESEARCH PRIORITIES
- Neurotrophin-replacement therapies
- NTRK1 and NGF pathway restoration platforms
- Peripheral nerve-regeneration technologies
- AI-driven injury-risk forecasting systems
- Autonomic-network stabilization therapeutics
- Small-fiber neuroprotection strategies
- Sensory-autonomic synchronization restoration platforms
MASTER REGISTRY INDEX
SCF-HSAN-0001 — Hereditary Sensory and Autonomic Neuropathies Master Registry
SCF-HSAN-SENSORY-0002 — Sensory Signaling Failure Layer
SCF-HSAN-AUTONOMIC-0003 — Autonomic Regulation Dysfunction Layer
SCF-HSAN-RHENOVA-0004 — Threat Detection Destabilization Layer
SCF-HSAN-DBI-0005 — Protective Intelligence Communication Failure Layer
SCF-HSAN-PCR-0006 — Preventative–Curative–Restorative Layer